DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-08-22
DOI
10.3389/fonc.2016.00187
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased DNA methylation of Dnmt3b targets impairs leukemogenesis
- (2016) I. Schulze et al. BLOOD
- Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure
- (2016) M. Mossner et al. BLOOD
- Clonal hematopoiesis in acquired aplastic anemia
- (2016) S. Ogawa BLOOD
- Assessment of Minimal Residual Disease in Standard-Risk AML
- (2016) Adam Ivey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- An experimentally validated network of nine haematopoietic transcription factors reveals mechanisms of cell state stability
- (2016) Judith Schütte et al. eLife
- De novo DNA methyltransferase DNMT3A: Regulation of oligomeric state and mechanism of action in response to pH changes
- (2015) Celeste Holz-Schietinger et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML
- (2015) T. N. Wong et al. BLOOD
- Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS
- (2015) Raya Mawad et al. BRITISH JOURNAL OF HAEMATOLOGY
- Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid Leukemia
- (2015) Alan H. Shih et al. CANCER CELL
- TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia
- (2015) J. Yamazaki et al. CANCER RESEARCH
- Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations
- (2015) Nicola K. Wilson et al. Cell Stem Cell
- Phase I Study of S-Trans, Trans-Farnesylthiosalicylic Acid (Salirasib), a Novel Oral RAS Inhibitor in Patients With Refractory Hematologic Malignancies
- (2015) Talha Badar et al. Clinical Lymphoma Myeloma & Leukemia
- Loss ofTET2in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis
- (2015) Kasper D. Rasmussen et al. GENES & DEVELOPMENT
- Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study
- (2015) E. M. Ocio et al. HAEMATOLOGICA
- DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype
- (2015) J. Nangalia et al. HAEMATOLOGICA
- Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial
- (2015) Alessandro Rambaldi et al. LANCET ONCOLOGY
- Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
- (2015) Christoph Röllig et al. LANCET ONCOLOGY
- Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells
- (2015) O A Guryanova et al. LEUKEMIA
- Graphical representation of clinical outcomes for patients with myelodysplastic syndromes
- (2015) David P. Steensma LEUKEMIA & LYMPHOMA
- CRL4VprBP E3 Ligase Promotes Monoubiquitylation and Chromatin Binding of TET Dioxygenases
- (2015) Tadashi Nakagawa et al. MOLECULAR CELL
- Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia
- (2015) Britta Will et al. NATURE MEDICINE
- Effect of Mutation Order on Myeloproliferative Neoplasms
- (2015) Christina A. Ortmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia
- (2015) Tetsuichi Yoshizato et al. NEW ENGLAND JOURNAL OF MEDICINE
- Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study
- (2015) E. M. Ocio et al. HAEMATOLOGICA
- DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype
- (2015) J. Nangalia et al. HAEMATOLOGICA
- HLX in AML: novel prognostic and therapeutic target
- (2015) Ashley Pandolfi et al. Oncotarget
- Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
- (2014) H. Dohner et al. BLOOD
- The R882H DNMT3A Mutation Associated with AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active Tetramers
- (2014) David A. Russler-Germain et al. CANCER CELL
- Dnmt3a and Dnmt3b Have Overlapping and Distinct Functions in Hematopoietic Stem Cells
- (2014) Grant A. Challen et al. Cell Stem Cell
- Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
- (2014) Alan S. Gamis et al. JOURNAL OF CLINICAL ONCOLOGY
- Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis
- (2014) M R Corces-Zimmerman et al. LEUKEMIA
- Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome
- (2014) Gail J. Roboz et al. LEUKEMIA & LYMPHOMA
- Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
- (2014) Liran I. Shlush et al. NATURE
- Structural insight into autoinhibition and histone H3-induced activation of DNMT3A
- (2014) Xue Guo et al. NATURE
- Discovery and saturation analysis of cancer genes across 21 tumour types
- (2014) Michael S. Lawrence et al. NATURE
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission
- (2014) M. R. Corces-Zimmerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chromatin state dynamics during blood formation
- (2014) D. Lara-Astiaso et al. SCIENCE
- Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation
- (2013) F. Ravandi et al. BLOOD
- Clinical and biological implications of driver mutations in myelodysplastic syndromes
- (2013) E. Papaemmanuil et al. BLOOD
- Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia
- (2013) Steven M. Chan et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial
- (2013) Hubert Serve et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence of tetracycline resistance genes and identification of tet(M) in clinical isolates of Escherichia coli from sick ducks in China
- (2013) G.-Z. Hu et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Ascorbic Acid Enhances Tet-Mediated 5-Methylcytosine Oxidation and Promotes DNA Demethylation in Mammals
- (2013) Ruichuan Yin et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells
- (2013) Kathryn Blaschke et al. NATURE
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX
- (2013) Myunggon Ko et al. NATURE
- Large conserved domains of low DNA methylation maintained by Dnmt3a
- (2013) Mira Jeong et al. NATURE GENETICS
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- CRL4 Complex Regulates Mammalian Oocyte Survival and Reprogramming by Activation of TET Proteins
- (2013) C. Yu et al. SCIENCE
- Concise Review: Preleukemic Stem Cells: Molecular Biology and Clinical Implications of the Precursors to Leukemia Stem Cells
- (2013) Ashley Pandolfi et al. Stem Cells Translational Medicine
- Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS
- (2012) L. Barreyro et al. BLOOD
- The Origin and Evolution of Mutations in Acute Myeloid Leukemia
- (2012) John S. Welch et al. CELL
- Hematopoiesis: A Human Perspective
- (2012) Sergei Doulatov et al. Cell Stem Cell
- Effects ofTET2mutations on DNA methylation in chronic myelomonocytic leukemia
- (2012) Jumpei Yamazaki et al. Epigenetics
- Mutations in DNA Methyltransferase (DNMT3A) Observed in Acute Myeloid Leukemia Patients Disrupt Processive Methylation
- (2012) Celeste Holz-Schietinger et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TET2 promotes histone O-GlcNAcylation during gene transcription
- (2012) Qiang Chen et al. NATURE
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia
- (2012) M. Jan et al. Science Translational Medicine
- Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors
- (2011) E. Pronier et al. BLOOD
- Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
- (2011) Z. Li et al. BLOOD
- TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
- (2011) Cyril Quivoron et al. CANCER CELL
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
- (2011) Kelly Moran-Crusio et al. CANCER CELL
- Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids
- (2011) Lakshminarayan M. Iyer et al. CELL CYCLE
- Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia
- (2011) Felicitas Thol et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
- (2011) M J Walter et al. LEUKEMIA
- GlcNAcylation of histone H2B facilitates its monoubiquitination
- (2011) Ryoji Fujiki et al. NATURE
- TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity
- (2011) Kristine Williams et al. NATURE
- Dnmt3a is essential for hematopoietic stem cell differentiation
- (2011) Grant A Challen et al. NATURE GENETICS
- Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia
- (2011) Xiao-Jing Yan et al. NATURE GENETICS
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytarabine Dose for Acute Myeloid Leukemia
- (2011) Bob Löwenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker
- (2011) M. Jan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
- (2011) S. Ito et al. SCIENCE
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
- (2010) Patrick S. Ward et al. CANCER CELL
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
- (2010) Yoshikane Kikushige et al. Cell Stem Cell
- Combinatorial Transcriptional Control In Blood Stem/Progenitor Cells: Genome-wide Analysis of Ten Major Transcriptional Regulators
- (2010) Nicola K. Wilson et al. Cell Stem Cell
- Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation
- (2010) Eric Hervouet et al. Epigenetics
- Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation
- (2010) Margaret Rush et al. Epigenetics
- The Dnmt3a PWWP Domain Reads Histone 3 Lysine 36 Trimethylation and Guides DNA Methylation
- (2010) Arunkumar Dhayalan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
- (2010) Myunggon Ko et al. NATURE
- Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification
- (2010) Shinsuke Ito et al. NATURE
- DNMT3AMutations in Acute Myeloid Leukemia
- (2010) Timothy J. Ley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chromatin methylation activity of Dnmt3a and Dnmt3a/3L is guided by interaction of the ADD domain with the histone H3 tail
- (2010) Yingying Zhang et al. NUCLEIC ACIDS RESEARCH
- Array-based genomic resequencing of human leukemia
- (2010) Y Yamashita et al. ONCOGENE
- Cancer-associated IDH mutations: biomarker and therapeutic opportunities
- (2010) K E Yen et al. ONCOGENE
- Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells
- (2010) Y. Saito et al. Science Translational Medicine
- Sin3: Master scaffold and transcriptional corepressor
- (2009) Adrienne Grzenda et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation
- (2009) G. Yoshimoto et al. BLOOD
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
- (2009) O. Abdel-Wahab et al. BLOOD
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX–DNMT3–DNMT3L domain
- (2009) Junji Otani et al. EMBO REPORTS
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- Acquired mutations in TET2 are common in myelodysplastic syndromes
- (2009) Saskia M C Langemeijer et al. NATURE GENETICS
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
- (2009) M. Tahiliani et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now